The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to tinostamustine, an investigational therapeutic from Purdue Pharma L.P., for the treatment of patients with malignant ...

Purdue Pharma L.P. ("Purdue") today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to its pipeline drug tinostamustine for the treatment of ...

A former aide to two New York governors is set to go on trial Wednesday on charges she sold her influence to the Chinese ...

The investigational, potentially first-in-class agent tinostamustine (EDO-S101) has earned FDA orphan drug designation (ODD) ...

MJH Life Sciences acquired BPD Healthcare, a 2025 MM+M Agency 100 honoree. Kenvue said it told the FDA its labeling request is unsupported by scientific evidence and would mark a departure from the ...

Some stories keep you up long past midnight, not because they demand it, but because they pull you in completely. These books change how you think, feel, and see the world, the kind you finish at ...

Lawyers representing OxyContin maker Purdue Pharma, branches of the Sackler family that own it, cities, states, counties, ...

While AI has accelerated drug discovery, the same technology can address clinical trial bottlenecks that have persisted for ...

STAMFORD, Conn.--(BUSINESS WIRE)--Purdue Pharma L.P. (“Purdue”) today announced that its Chapter 11 Plan of Reorganization (“Plan”) received support from more than 99% of voting creditors, based on ...

NEW YORK, Oct 21 (Reuters) - More than 99% of bankrupt drugmaker Purdue Pharma's creditors voted to accept a $7.4 billion settlement of legal claims related to the company's sales of addictive opioid ...

Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer fully protects the company’s owners, members of the Sackler families, from ...